EWP
KRSA

Elevation Wealth Partners’s Korsana Biosciences, Inc. Common Stock KRSA Stock Holding History

Elevation Wealth Partners’s Portfolio KRSA Stock Details KRSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3
Closed -$50 – 492
2025
Q1 		$50 Hold
3
– – ﹤0.01% 477
2024
Q4 		$65 Buy
+3
New +$8 ﹤0.01% 482

Other funds holding KRSA

TCP
Tyndall Capital Partners New York $452K AUM 26.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

Elevation Wealth Partners's KRSA Position: Q2 2025 in Review

Elevation Wealth Partners sold out of Korsana Biosciences, Inc. Common Stock (KRSA) in Q2 2025, closing a stake of 3 shares — an estimated $50 sold.

Elevation Wealth Partners first reported a position in KRSA in Q4 2024 and held it in 2 quarters. The position peaked at $65 in Q4 2024. 17 funds tracked by Wall St. Rank hold KRSA as of Q2 2025.

  • Elevation Wealth Partners reported no remaining Korsana Biosciences, Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
  • Elevation Wealth Partners sold 3 Korsana Biosciences, Inc. Common Stock shares in Q2 2025, an estimated $50.
  • Elevation Wealth Partners first reported a position in Korsana Biosciences, Inc. Common Stock in Q4 2024 and held it in 2 quarters.
  • Elevation Wealth Partners's Korsana Biosciences, Inc. Common Stock position peaked at $65 in Q4 2024.
  • 17 funds tracked by Wall St. Rank held Korsana Biosciences, Inc. Common Stock as of Q2 2025.

Based on Elevation Wealth Partners's 13F filing for Q2 2025, filed 8 Jul 2025.